Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 8/20 | 0.62 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.57 |
| ▸ | PRKDC | P78527 | 1/20 | 0.47 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.43 |
| ▸ | IDO1 | P14902 | 2/20 | 0.40 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.40 |
| ▸ | TNKS | O95271 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.39 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24097372 | 0.94 | AHR (0.66) | AHRALOX5PRKDCGGPS1PTGES2 | |
| SCHEMBL22129981 | 0.94 | AHR (0.66) | AHRALOX5PRKDCGGPS1PTGES2 | |
| SCHEMBL23314431 | 0.92 | AHR (0.52) | AHRALOX5PRKDCGGPS1IDO1 | |
| SCHEMBL21756062 | 0.90 | AHR (0.54) | AHRALOX5PRKDCGGPS1PTGES2 | |
| SCHEMBL1635447 | 0.89 | ALOX5 (0.66) | AHRALOX5PRKDCGGPS1PTGES2 | |
| SCHEMBL20277131 | 0.89 | ALOX5 (0.69) | AHRALOX5PRKDCGGPS1PTGES2 | |
| SCHEMBL12069400 | 0.89 | ALOX5 (0.69) | AHRALOX5PRKDCGGPS1PTGES2 | |
| SCHEMBL24264017 | 0.88 | AHR (0.64) | AHRALOX5IDO1TNKSKDM4E | |
| SCHEMBL1637355 | 0.87 | ALOX5 (0.64) | AHRALOX5PRKDCGGPS1PTGES2 | |
| SCHEMBL22738104 | 0.87 | AHR (0.71) | AHRALOX5PRKDCGGPS1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11832517-B2 | Heterocyclic compound and organic light emitting device comprising same | LG CHEM, LTD. (KR) | 2023-11-28 | — | — | US | disclosed |
| US-11832517-B2 | Heterocyclic compound and organic light emitting device comprising same | LG CHEM, LTD. (KR) | 2023-11-28 | — | — | US | disclosed |
| US-20230172065-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-06-01 | — | — | US | disclosed |
| US-20230172065-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-06-01 | — | — | US | disclosed |
| US-20220059778-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2022-02-24 | — | — | US | disclosed |
| WO-2022015084-A1 | ORGANIC LIGHT-EMITTING ELEMENT | 주식회사 엘지화학 | 2022-01-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220059778-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | CRY1, TRPC1, CYP1A1 | AHR 56/4885ALOX5 1152/4885PRKDC 4335/4885 |
| US-20230172065-A1 | ORGANIC LIGHT EMITTING DEVICE | CRY1, CYP1A2, CYP1A1 | AHR 474/4885ALOX5 1552/4885PRKDC 3767/4885 |
| US-11832517-B2 | Heterocyclic compound and organic light emitting device comprising same | CRY1, TRPC1, CYP1A1 | AHR 56/4885ALOX5 1152/4885PRKDC 4335/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.